Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04885179 · ClinicalTrials.gov registry record
SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)
A clinical trial of Sphingolipidoses and Enzyme Deficiency, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT04885179: Recruiting study of Sphingolipidoses and Enzyme Deficiency, sponsored by University of California, San Francisco.
NCT04885179 is a study of Sphingolipidoses and Enzyme Deficiency that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04885179, a study of Sphingolipidoses and Enzyme Deficiency, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol aims to gather information about sphingosine phosphate lyase insufficiency syndrome (SPLIS), also known as NPHS14, and to create a SPLIS patient registry. Medical records, radiological and pathology results, blood test results, and genetic information will be collected. Samples of blood, cheek cells, urine and stool may be collected for analysis. If a skin biopsy has been performed for medical care, cells from the biopsy may be analyzed. No treatment or other intervention is involved in this study. However, the effect of treatments administered by the patient's physician may be detected and monitored based on changes in the blood or urine.
Primary Outcome
The primary outcome of this study is survival (age at death).
Conditions Studied
Interventions
- OTHER no intervention
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-04-22 |
| Est. Completion | 2028-12-30 |
What NCT04885179 shows while recruiting
NCT04885179 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Sphingolipidoses appearing as the primary indexed condition, and to 1 intervention - of which no intervention is the first listed.
NCT04885179 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04885179 about?
NCT04885179 is a clinical study titled "SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)". This protocol aims to gather information about sphingosine phosphate lyase insufficiency syndrome (SPLIS), also known as NPHS14, and to create a SPLIS patient registry. Medical records, radiological and pathology results, blood test results, and genetic information will be collected. Samples of bloo...
What is the current status of trial NCT04885179?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-04-22. Estimated completion is 2028-12-30.
What conditions does trial NCT04885179 study?
This clinical trial studies the following conditions: Sphingolipidoses, Enzyme Deficiency.
What interventions are being tested in trial NCT04885179?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT04885179?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04885179 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sphingolipidoses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI